Diagnostic Accuracy of 10/66 Dementia Protocol in Fijian-Indian Elders Living in New Zealand.

10/66 dementia protocol Alzheimer’s diseases Fijian-Indian community dementia dementia prevalence

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
03 05 2021
Historique:
received: 17 03 2021
revised: 08 04 2021
accepted: 30 04 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 22 6 2021
Statut: epublish

Résumé

The 10/66 dementia protocol was developed as a language and culture-fair instrument to estimate the prevalence of dementia in non-English speaking communities. The aim of this study was to validate the 10/66 dementia protocol in elders of Indian ethnicity born in the Fiji Islands (Fijian-Indian) living in New Zealand. To our knowledge, this is the first time a dementia diagnostic tool has been evaluated in the Fijian-Indian population in New Zealand. We translated and adapted the 10/66 dementia protocol for use in in Fijian-Indian people. Individuals (age ≥ 65) who self-identified as Fijian-Indian and had either been assessed for dementia at a local memory service (13 cases, eight controls) or had participated in a concurrent dementia prevalence feasibility study (eight controls) participated. The sensitivity, specificity, positive predictive value, and Youden's index were obtained by comparing the 10/66 diagnosis and its sub-components against the clinical diagnosis (reference standard). The 10/66 diagnosis had a sensitivity of 92.3% (95% CI 70.3-99.5), specificity of 93.8% (95% CI 75.3-99.6), positive predictive value of 92.3% (95% CI 70.3-99.5), and negative predictive value of 93.8% (95% CI 75.3-99.6). The study results show that the Fijian-Indian 10/66 dementia protocol has adequate discriminatory abilities to diagnose dementia in our sample. This instrument would be suitable for future dementia population-based studies in the Fijian-Indian population living in Aotearoa/New Zealand or the Fiji-Islands.

Identifiants

pubmed: 34063626
pii: ijerph18094870
doi: 10.3390/ijerph18094870
pmc: PMC8124794
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int Psychogeriatr. 2004 Mar;16(1):13-31
pubmed: 15190994
J Neuropathol Exp Neurol. 2012 Apr;71(4):266-73
pubmed: 22437338
Br J Psychiatry Suppl. 2000;(39):s28-33
pubmed: 10945075
Popul Health Metr. 2016 Nov 25;14:45
pubmed: 27905979
Dement Geriatr Cogn Disord. 2016;41(1-2):46-54
pubmed: 26613533
Int Psychogeriatr. 2009 Jun;21(3):604-5
pubmed: 19216821
J Diabetes. 2016 Jul;8(4):533-43
pubmed: 26201444
Alzheimer Dis Assoc Disord. 2020 Apr-Jun;34(2):163-169
pubmed: 31651419
Gerontologist. 1986 Jun;26(3):260-6
pubmed: 3721233
Am J Geriatr Psychiatry. 2005 Jul;13(7):581-8
pubmed: 16009734
Diabet Med. 1996 Feb;13(2):125-32
pubmed: 8641116
Psychol Med. 1989 Nov;19(4):1015-22
pubmed: 2594878
Lancet. 2003 Mar 15;361(9361):909-17
pubmed: 12648969
J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):416-8
pubmed: 8163988
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Psychol Med. 1986 Feb;16(1):89-99
pubmed: 3515380
Neurology. 1989 Sep;39(9):1159-65
pubmed: 2771064
Int J Geriatr Psychiatry. 2001 Sep;16(9):912-7
pubmed: 11571773
Int J Geriatr Psychiatry. 2018 Aug;33(8):1098-1104
pubmed: 29766582
Geriatr Gerontol Int. 2013 Jul;13(3):687-93
pubmed: 23186020
Cochrane Database Syst Rev. 2015 Mar 10;(3):CD010772
pubmed: 25754745
BMC Public Health. 2008 Jun 24;8:219
pubmed: 18577205
J Hum Genet. 2015 Feb;60(2):69-75
pubmed: 25566758
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
J Alzheimers Dis. 2015;45(4):1127-38
pubmed: 25672767
Psychol Rep. 1999 Jun;84(3 Pt 1):927-35
pubmed: 10408215
Psychol Med. 1994 Feb;24(1):145-53
pubmed: 8208879
Gerontologist. 1980 Dec;20(6):649-55
pubmed: 7203086
Indian J Psychiatry. 2009 Jan;51 Suppl 1:S8-S15
pubmed: 21416024
Expert Rev Neurother. 2018 Nov;18(11):859-869
pubmed: 30286681
Neurology. 1993 Feb;43(2):250-60
pubmed: 8094895
J Clin Diagn Res. 2016 Oct;10(10):YE01-YE06
pubmed: 27891446
Int Psychogeriatr. 2011 Jun;23(5):788-96
pubmed: 21223627
Clin Neuropsychol. 2021 Apr;35(3):660-678
pubmed: 31951511
Int Psychogeriatr. 2015 Jun;27(6):981-9
pubmed: 25603424
Int J Geriatr Psychiatry. 2000 Jun;15(6):521-31
pubmed: 10861918
Acta Neurol Scand. 2012 Jan;125(1):16-23
pubmed: 21198445
Arch Clin Neuropsychol. 2010 Mar;25(2):139-45
pubmed: 20064817
Neurology. 2000 Dec 26;55(12):1854-62
pubmed: 11134385
BMC Public Health. 2007 Jul 20;7:165
pubmed: 17659078
Arq Neuropsiquiatr. 2006 Mar;64(1):35-40
pubmed: 16622550
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Gerontologist. 1991 Feb;31(1):9-14
pubmed: 2007480
J Geriatr Psychiatry Neurol. 2014 Sep;27(3):212-9
pubmed: 24614204
Dement Geriatr Cogn Disord. 2013;36(5-6):354-62
pubmed: 24022429
CMAJ. 2015 Mar 17;187(5):E169-75
pubmed: 25691786
J Geriatr Psychiatry Neurol. 2014 Dec;27(4):282-90
pubmed: 24771602
Int Psychogeriatr. 2006 Mar;18(1):111-20
pubmed: 16466591
N Z Med J. 2011 May 13;124(1334):21-34
pubmed: 21946633
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9
pubmed: 11001602
Int Psychogeriatr. 2004 Sep;16(3):275-93
pubmed: 15559753
Br J Psychiatry. 1988 Feb;152:209-13
pubmed: 3167337

Auteurs

Adrian Martinez-Ruiz (A)

Department of Psychological Medicine, The University of Auckland, Level 3, Building 507, 22-30 Park Avenue, Grafton, Auckland 1142, New Zealand.
Department of Demographic Epidemiology and Social Determinants, National Institute of Geriatrics, Anillo Perif. 2767, San Jerónimo Lídice, La Magdalena Contreras, Ciudad de México 10200, Mexico.

Rita Krishnamurthi (R)

National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, 55 Wellesley Street East, Auckland 1010, New Zealand.

Ekta Singh Dahiya (ES)

National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, 55 Wellesley Street East, Auckland 1010, New Zealand.

Reshmi Rai-Bala (R)

Department of Psychological Medicine, The University of Auckland, Level 3, Building 507, 22-30 Park Avenue, Grafton, Auckland 1142, New Zealand.

Sanjalin Naicker (S)

Department of Psychological Medicine, The University of Auckland, Level 3, Building 507, 22-30 Park Avenue, Grafton, Auckland 1142, New Zealand.

Susan Yates (S)

Department of Psychological Medicine, The University of Auckland, Level 3, Building 507, 22-30 Park Avenue, Grafton, Auckland 1142, New Zealand.

Claudia Rivera Rodriguez (C)

Department of Statistics, The University of Auckland, Level 3, Building 303, 38 Princes Street, Auckland 1010, New Zealand.

Gary Cheung (G)

Department of Psychological Medicine, The University of Auckland, Level 3, Building 507, 22-30 Park Avenue, Grafton, Auckland 1142, New Zealand.

Makarena Dudley (M)

School of Psychology, The University of Auckland, Science Centre Level 2, Building 302, 23 Symonds Street, Auckland 1010, New Zealand.

Ngaire Kerse (N)

School of Population Health, The University of Auckland, Level 3, Building 507, 22-30 Park Avenue, Grafton, Auckland 1142, New Zealand.

Sarah Cullum (S)

Department of Psychological Medicine, The University of Auckland, Level 3, Building 507, 22-30 Park Avenue, Grafton, Auckland 1142, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH